Will Smith's wife, and her son, Jaden, lead a "Red Table Talk" about psychedelics with author Michael Pollan and other guests.
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Jada_Pinkett_Smith_Jaden_Psilocybin_Depresion_Red_Table_Talk_Psychedelic_Spotlight.jpg8751310Travis Reillyhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngTravis Reilly2021-11-11 18:04:552021-11-11 18:04:55Jada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression’ in ‘Red Table Talk’ About PsychedelicsShutterstock.com
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways' novel drug formulation COMP360.
4-Bromo-2,5-dimethoxyphenethylamine (also known as Nexus, Erox, or 2C-B) was synthesized by a famous American pharmacologist and psychonaut, Alexander Shulgin, in 1974.
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Forgotten_Psychedelics_What_Is_2C-B_Psychedelic_Spotlight.jpg8751310Evan Lewis-Healeyhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngEvan Lewis-Healey2021-11-09 17:49:322021-11-09 17:49:32Forgotten Psychedelics: What Is 2C-B?NBC/Today Show
Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration of effect, and improved brain penetration.
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Cybin_Novel_Analog_CYB003_Advantages_Over_Oral_Psilocybin_Psychedelic_Spotlight.jpg8751310Emily Jarviehttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngEmily Jarvie2021-11-08 18:16:112022-02-25 18:09:00Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Psychedelic_Spotlight_Business_Roundup_Nov_5_Cybin_Compass_Pathways_Filament_Revive_Tryp_Mydecine.jpg9621920Emily Jarviehttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngEmily Jarvie2021-11-05 17:05:012022-06-07 23:23:33Psychedelic Business Spotlight: November 5Shutterstock.com
Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it.
The Phase-2…
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Compass_Pathways_Clinical_Trial_Psilocybin_PTSD_Psychedelic_Spotlight.jpg8751310James Hallifaxhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngJames Hallifax2021-11-04 21:35:152021-11-04 21:35:15Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy Session
TreatmentJada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression’ in ‘Red Table Talk’ About Psychedelics
CultureMAPS Expands MDMA-Assisted Therapy for PTSD Trial Into Canada
TreatmentLargest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce
Business, ResearchForgotten Psychedelics: What Is 2C-B?
CultureVeteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors
CultureCybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’
BusinessPsychedelic Business Spotlight: November 5
Business, Stock ReportsWhy We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
Business, ResearchFDA Approves First Clinical Trial Using Naturally Sourced Psychedelics
Business